bioRxiv Science⌕ Search

Biology subjects

Giannakopoulou, E.

Publications and source records attributed to Giannakopoulou, E..

2 recordsLinked to original sources

Immediate transcriptional changes initiated by direct cell-cell contact between cytotoxic T cells and cancer cells

Many biological processes are regulated by the direct interaction between two or more cell types. However, our understanding of the immediate dynamic changes in gene transcription upon physical interaction between two cells has remained limited due to technical limitations. Here we address these limitations in a model system of cancer-specific T cell receptor (TCR)-modified CD8 T cells where single and cancer-interacting T cells were isolated by image-enabled cell sorting and transcripts from heterotypic cancer cell and T cell pairs were in silico assigned. This approach uncovers immediate, dynamic changes in gene expression following the specific interaction between TCR-modified CD8 T cells and cancer cells. In addition to dissecting transcriptional cascades dependent on the peptide sensitivity of the TCR, we for the first time directly compare these gene expression changes between single T cells and T cells in direct physical contact with cancer cells. Modeling of the observed transcriptomic activation signature identifies phenotypically distinct tumor infiltrating CD8 T cell subsets associated with reduced TCR diversity in in vivo datasets. Taken together, the paradigm developed here allows for future clonal identification of T cell receptors mediating ongoing effective cytotoxic responses in vivo.

immunology↗

Metal Coordinating Inhibitors of Rift Valley Fever virus Replication

Rift Valley Fever Virus (RVFV) is a veterinary and human pathogen and is an agent of bioterrorism concern. Currently, RVFV treatment is limited to supportive care, so new drugs to control RVFV infection are urgently needed. RVFV is a member of the Bunyavirales order, and replication of these viruses depends on the viral endonuclease activity of the viral L protein. Screening for RVFV replication inhibitors among compounds with divalent cation-coordinating motifs similar to known viral nuclease inhibitors identified 31 novel RVFV inhibitors with selective indexes from 5 - 402 and 50% effective concentrations of 0.54 - 56 {micro}M in Vero cells, primarily -Hydroxytropolones and N-Hydroxypyridinediones. Inhibitor activity and selective index was validated in the human cell line A549. To evaluate specificity, select compounds were tested against another Bunyavirus, La Crosse Virus (LACV). Conservation of the enzymatic activity such as the cap-snatching mechanism among the Bunyavirales implies that the -Hydroxytropolone and N-Hydroxypyridinedione chemotypes hold potential for development into treatments for related pathogens, including Hantaan Virus, Severe fever with thrombocytopenia syndrome virus, Crimean-Congo Hemorrhagic Fever Virus, and LACV. Keywords: Rift Valley Fever Virus 1, La Crosse virus 2, Cap-snatching endonuclease 3, Replication inhibitors 4, -Hydroxytropolones 5, N-Hydroxypyridinediones 6.

microbiology↗